A look at the ASEAN-NDI: building a regional health R&D innovation network

Infectious Diseases of Poverty

Bernadette Ramirez¹  Nico Angelo C Parungao²  Carina L Rebulanan²  Jaime C Montoya² 

[1]UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland

[2]Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD), Taguig City, Philippines

关键词: Strategic business plan;    Innovation network;    Infectious tropical diseases;    Health research and development;    ASEAN-NDI;   

Others  :  800962
DOI  :  10.1186/2049-9957-3-15

 received in 2013-10-29, accepted in 2014-04-22,  发布年份 2014

【 摘 要 】

Globally, there are growing efforts to address diseases through the advancement in health research and development (R&D), strengthening of regional cooperation in science and technology (particularly on product discovery and development), and implementation of the World Health Assembly Resolution 61.21 (WHA61.21) on the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property (GSPA-PHI). As such, the Association of Southeast Asian Nations (ASEAN) is responding to this through the establishment of the ASEAN-Network for Drugs, Diagnostics, Vaccines, and Traditional Medicines Innovation (ASEAN-NDI). This is important in the ASEAN considering that infectious tropical diseases remain prevalent, emerging, and reemerging in the region. This paper looks into the evolution of the ASEAN-NDI from its inception in 2009, to how it is at present, and its plans to mitigate public health problems regionally and even globally.

【 授权许可】

   
2014 Montoya et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Population Reference Bureau: 2010 World population data sheet. Washington: Population Reference Bureau; 2010.
• [2]World Health Organization: Neglected tropical diseases. 2010. [http://www.who.int/neglected_diseases/ webcite]
• [3]UNESCO Institute of Statistics: Data tables. 2010. [http://stats.uis.unesco.org/unesco/ReportFolders webcite. Accessed September 2010]
• [4]Ng L: ASEAN Country report outline: Singapore: product R&D landscape for infectious tropical diseases in ASEAN member States. Manila: ASEAN-NDI Secretariat; 2010.
• [5]Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N: Drug development for neglected diseases: a deficient market and a public health policy failure. Lancet 2002, 359:2188-2194.
• [6]Department of Science and Technology: Compendium of science and technology statistics. Manila: DOST; 2008.
• [7]World Health Assembly: Global strategy and plan of action on public health, innovation, and intellectual property (WHA 61.21). WHA; 2008. [http://apps.who.int/gb/ebwha/pdf_files/A61/A61_R21-en.pdf webcite]
• [8]Nwaka S, Ilunga TB, Da Silva JS, Rial Verde E, Hackley D, De Vre R, Ridley R: Developing ANDI: a novel approach to health product R&D in Africa. PLoS Med 2010, 7(6):e1000293. doi: 10.1371/journal.pmed.1000293
• [9]ClinicalTrials.gov: Map of studies in Southeast Asia. 2013. [http://clinicaltrials.gov/ct2/search/map?map=SE webcite]
• [10]ASEAN-NDI: Product R&D landscape for infectious tropical diseases in ASEAN member States. Manila: ASEAN-NDI Secretariat; 2010.
• [11]Elsevier: Scopus database. 2010. [http://scopus.com webcite]
• [12]ASEAN-NDI: Strategic business plan. Manila: ASEAN-NDI Secretariat; 2013.
• [13]Porter ME, Teisberg EO: Redefining health care: creating value-based competition on results. Boston: Harvard Business School Publishing; 2006.
• [14]African Network for Drugs and Diagnostics Innovation: Strategic and business plan for the African network for drugs and diagnostics innovation. WHO-TDR; 2009. [http://www.who.int/tdr/publications/documents/sbp_andi.pdf webcite. Page 28]
• [15]ASEAN Secretariat: 15th ASEAN Ministerial Meeting on Science and Technology: Chairman’s Statement. 2013. [http://www.asean.org/images/Statement/2013/chairmans%20statement%20of%20ammst-15%20%2013nov2013.pdf webcite]
• [16]Hotez PJ, Gurwith M: Europe’s neglected infections of poverty. Int J Infect Dis 2011, 2011(15):e611-e619.
• [17]McNeil DG Jr: Global update: Europe: increase in tropical diseases is aided by migration and weak economies. The New York Times; 2011. [http://www.nytimes.com/2011/08/02/health/02global.html?_r=0 webcite]
• [18]Hotez PJ, Savioli L, Fenwick A: Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop 2012, Dis 6:e1475. doi:10.1371/journal.pntd.0001475
• [19]Hotez PJ, Papageorgiou TD: A new European neglected diseases center for Greece? PLoS Negl Trop Dis 2013, 7(2):e1757. doi: 10.1371/journal.pntd.0001757
• [20]Hotez PJ, Kamath A: Neglected tropical diseases in Sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009, 3(8):e412. doi: 10.1371/journal.pntd.0000412
• [21]Lobo DA, Velayudhan R, Chatterjee P, Kohli H, Hotez PJ: The neglected tropical diseases of India and South Asia: review of their prevalence, distribution, and control or elimination. PLoS Negl Trop Dis 2011, 5(10):e1222. doi: 10.1371/journal.pntd.0001222
• [22]Bergquist R, Whittaker M: Control of neglected tropical diseases in Asia Pacific: implications for health information priorities. Infect Dis Poverty 2012, 1:3. doi:10.1186/2049-9957-1-3 BioMed Central Full Text